In a patient with rheumatoid arthritis taking NSAIDs who presents with weakness, dizziness, syncope, hypotension, tachycardia, and normal temperature, which finding should the nurse suspect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Decreased H&H (Hemoglobin and Hematocrit)

The nurse should suspect decreased hemoglobin and hematocrit (H&H) in this patient, as the clinical presentation of weakness, dizziness, syncope, hypotension (BP 96/50), and tachycardia (HR 105) in a rheumatoid arthritis patient on chronic NSAID therapy is highly suggestive of acute gastrointestinal bleeding leading to hypovolemic shock.

Clinical Reasoning

NSAID-Related Gastrointestinal Bleeding Risk

  • NSAIDs are widely prescribed for rheumatoid arthritis but carry significant risk of gastrointestinal toxicity, including bleeding, due to inhibition of cyclooxygenase and subsequent reduction in protective prostaglandin production 1, 2.

  • The adverse effects of NSAIDs, particularly gastroduodenal diseases, are induced by inhibition of cyclooxygenase which reduces prostaglandin content that normally protects the gastric mucosa 3.

  • Chronic NSAID use in patients with rheumatoid arthritis can lead to serious gastrointestinal complications including ulceration and bleeding 4, 2.

Hemodynamic Profile Consistent with Acute Blood Loss

  • The patient's vital signs demonstrate classic signs of hypovolemic shock: hypotension (BP 96/50 with MAP 65), compensatory tachycardia (HR 105), and tachypnea (RR 24) 5.

  • The absence of fever (temperature 37°C) makes sepsis less likely, as infectious processes typically present with elevated temperature 5.

  • The triad of weakness, dizziness, and syncope in the context of hypotension and tachycardia strongly suggests inadequate tissue perfusion from acute blood loss rather than orthostatic hypotension, sepsis, or autoimmune phenomena 6, 7.

Why Other Options Are Less Likely

Increased GFR (Glomerular Filtration Rate)

  • This is physiologically implausible in this clinical scenario; acute blood loss and hypotension would decrease GFR, not increase it 2.

  • NSAIDs are associated with renal insufficiency and decreased renal function, not increased GFR 1, 3.

Positive Sepsis Screen

  • The normal temperature (37°C/98.6°F) makes sepsis unlikely, as septic patients typically present with fever or hypothermia 5.

  • While tachycardia and hypotension can occur in sepsis, the absence of fever and the specific context of chronic NSAID use in a rheumatoid arthritis patient makes gastrointestinal bleeding the more probable diagnosis 5.

Decreased Antinuclear Antibody (ANA) Assay

  • ANA levels do not acutely decrease in response to NSAID use or acute bleeding episodes 5.

  • Changes in ANA titers are not relevant to the acute presentation of weakness, dizziness, syncope, and hemodynamic instability 5.

  • This finding would not explain the patient's acute hemodynamic compromise 5.

Immediate Clinical Implications

  • The patient requires urgent assessment of hemoglobin and hematocrit levels to confirm acute blood loss anemia 5.

  • Immediate interventions should include intravenous access, fluid resuscitation, type and crossmatch for potential blood transfusion, and gastroenterology consultation for possible endoscopy 5.

  • NSAIDs should be discontinued immediately given the high probability of NSAID-induced gastrointestinal bleeding 2.

References

Research

New drugs for the treatment of rheumatoid arthritis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000

Research

Use of NSAIDs in treating patients with arthritis.

Arthritis research & therapy, 2013

Research

[NSAIDs (non steroidal anti-inflammatory drugs) for the treatment of rheumatoid arthritis].

Nihon rinsho. Japanese journal of clinical medicine, 1992

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Orthostatic Blood Pressure Measurement Technique

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Orthostatic Hypotension Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment plan for reactive arthritis, including first‑line NSAIDs, corticosteroids, antibiotics for Chlamydia, disease‑modifying antirheumatic drugs, and biologic therapy?
What is the best treatment approach for a rheumatoid arthritis (RA) flare-up in the right hand as a Family Nurse Practitioner (FNP)?
What is the best Non-Steroidal Anti-Inflammatory Drug (NSAID) for Rheumatoid Arthritis (RA)?
What is the recommended initial treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for a patient with rheumatic joint pain?
What is the safest nonsteroidal anti-inflammatory drug (NSAID) for an elderly woman with rheumatoid arthritis (RA)?
In a 17-year-old with hyperglycemia and anemia (hemoglobin 11.8 g/dL, hematocrit 35.2%), what laboratory test should be ordered next?
What hemoglobin level should trigger red blood cell transfusion in a stable adult with metastatic castration‑resistant prostate cancer receiving anti‑androgen therapy (abiraterone, enzalutamide, apalutamide, or darolutamide), considering anemia symptoms and cardiovascular comorbidity?
What is the initial work‑up for a suspected pituitary adenoma?
I have an elevated thyroid‑stimulating hormone (TSH) level of 7.12 µIU/mL; what does this indicate and how should it be managed?
In a stable adult with metastatic castration‑resistant prostate cancer receiving an anti‑androgen (abiraterone, enzalutamide, apalutamide, or darolutamide) and who has cardiovascular disease, what platelet transfusion thresholds should be used?
In a stable 50‑year‑old man with diabetes on postoperative day 3 after open abdominal surgery who develops a localized tender erythematous incision swelling without fever, what is the best management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.